Medicine and Dentistry
Breast Cancer
95%
Disease
86%
Malignant Neoplasm
81%
Asthma
62%
Neoplasm
56%
Oncology
45%
Women's Health
44%
Wheeze
37%
Hazard Ratio
36%
Prostate Cancer
33%
Symptom
32%
Physical Activity
30%
Heart Failure
30%
Postmenopause
30%
Biological Marker
27%
Nodular Melanoma
27%
Clinical Trial
27%
Colorectal Cancer
26%
Cardiovascular Disease
26%
Placebo
26%
Radiation Therapy
24%
Overall Survival
23%
Cancer Risk
23%
Obstructive Sleep Apnea
23%
Odds Ratio
21%
Non Small Cell Lung Cancer
21%
Body Mass Index
20%
Metastatic Carcinoma
20%
Myocardial Infarction
18%
Cyclophosphamide
17%
Pediatrics
17%
Prostate Carcinoma
17%
Doxorubicin
16%
Sleep Time
16%
Recurrent Disease
16%
In Vitro
16%
Diagnosis
16%
Surgery
16%
Quality of Life
15%
Coronary Artery Disease
15%
Cardiovascular System
15%
Randomized Controlled Trial
15%
Cisplatin
15%
Childbirth
14%
Chronic Obstructive Pulmonary Disease
14%
Tumor Cell
14%
Systematic Review
14%
COVID-19
14%
Biopsy
14%
Lung Transplantation
14%
Sleep Medicine
14%
Small Cell Lung Cancer
13%
Metastatic Breast Cancer
13%
Diabetes
13%
Cancer Prevention
13%
Cancer Mortality
13%
Drug Therapy
13%
Prevalence
13%
Gene Expression
12%
Dietary Pattern
12%
Respiratory Disease
12%
Adenoma
12%
Bone Marrow Transplantation
12%
Ovarian Cancer
12%
Colon Cancer
12%
Magnetic Resonance Imaging
12%
Acute Myeloid Leukemia
12%
Disease Free Survival
11%
Proportional Hazards Model
11%
Arm
11%
Phase II Trials
11%
Infection
11%
Tamoxifen
11%
Adjuvant Therapy
11%
Sleep Disorder
11%
Acute Heart Infarction
11%
Etoposide
10%
Drug Megadose
10%
Heart Failure with Preserved Ejection Fraction
10%
Health Care Cost
10%
Metabolic Syndrome
10%
Obesity
10%
Positron Emission Tomography
10%
Colorectal Adenoma
10%
Positive Airway Pressure
10%
Metastatic Melanoma
10%
Artificial Respiration
9%
Cohort Analysis
9%
Autologous Bone Marrow Transplantation
9%
Prostate Specific Antigen
9%
Epithelial Cell
9%
Epileptic Absence
9%
Cancer Therapy
9%
Integrin
9%
Observational Study
9%
Diet Therapy
9%
Pulmonary Hypertension
9%
Prognostic Factor
9%
Angina Pectoris
8%
Protein P53
8%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Asthma
77%
Breast Cancer
74%
Malignant Neoplasm
64%
Neoplasm
62%
Chemotherapy
56%
Mouse
55%
Placebo
41%
Cyclophosphamide
41%
Heart Failure
39%
Doxorubicin
38%
Nonalcoholic Fatty Liver
37%
Prostate Cancer
35%
Melanoma
33%
Cisplatin
33%
Symptom
32%
Clinical Trial
30%
Sleep Disordered Breathing
30%
Acute Heart Infarction
29%
Pharmacokinetics
28%
Heart Infarction
26%
Wheezing
26%
Biological Marker
26%
Overall Survival
25%
Phase II Trials
23%
Non Small Cell Lung Cancer
22%
Cardiovascular Disease
19%
Heart Failure with Preserved Ejection Fraction
19%
Metastatic Breast Cancer
19%
Prostate Carcinoma
18%
Small Cell Lung Cancer
18%
Etoposide
17%
Remission
17%
Lung Cancer
17%
Chronic Obstructive Lung Disease
17%
Prevalence
17%
Nanoparticle
17%
Progression Free Survival
15%
Dry Powder Inhaler
15%
Paclitaxel
15%
Solid Malignant Neoplasm
15%
Colorectal Cancer
15%
Infection
14%
Imexon
14%
Recurrent Disease
13%
Inflammation
13%
Immunotherapy
13%
Disease Free Survival
13%
Colon Cancer
13%
Sleep Disorder
12%
Metastatic Melanoma
12%
Obesity
12%
Prostate Specific Antigen
12%
Adverse Event
12%
Anticarcinogen
11%
Survival Rate
11%
Cohort Study
11%
Spironolactone
10%
Cytotoxicity
10%
Receptor
10%
Adult Respiratory Distress Syndrome
10%
Xenobiotic Agent
10%
Coronary Artery Disease
10%
Elimination
10%
Metastasis
10%
Colorectal Adenoma
10%
Acute Myeloid Leukemia
10%
Tamoxifen
10%
Bile Acid
9%
Mitomycin
9%
Vincristine
9%
Tumor Necrosis Factor
9%
Pancreas Cancer
9%
Nanomedicine
9%
Mycobacterium Bovis BCG
9%
Pulmonary Hypertension
9%
Microparticle
8%
Epileptic Absence
8%
Liposome
8%
Denosumab
8%
Vinorelbine
8%
Mouse Model
8%
Randomized Clinical Trial
8%
Antihypertensive Agent
8%
Myeloma
8%
Cell Culture
8%
Coronavirinae
8%
Dacarbazine
8%
Antitumor Activity
8%
Vitamin D
8%
Fluorouracil
8%
Docetaxel
8%
Protein P53
8%
Matrilysin
7%
Bone Metastasis
7%
Methionine
7%
Adenoma
7%
Paracetamol
7%
Nitric Oxide
7%
Disease Exacerbation
7%
Keyphrases
Asthma
61%
Confidence Interval
49%
Breast Cancer
39%
Southwest Oncology Group
38%
Women's Health Initiative
36%
Wheezing
29%
Hazard Ratio
29%
Physical Activity
26%
Postmenopausal Women
25%
Obesity
24%
Group Studies
23%
Odds Ratio
23%
Chemotherapy
23%
Insomnia
22%
Body Mass Index
21%
Tumor
21%
Sleep Duration
20%
Acute Myocardial Infarction
20%
Risk Factors
20%
Cisplatin
18%
Prostate Cancer
18%
Phase II Trial
17%
Obstructive Sleep Apnea
16%
Cyclophosphamide
16%
Placebo
16%
Lymphocytes
15%
Colorectal Cancer
15%
Clinical Trials
15%
United States
14%
Heart Failure with Preserved Ejection Fraction (HFpEF)
14%
Heart Failure
14%
Melanoma
14%
In Cancer
14%
Nonalcoholic Steatohepatitis
13%
Imexon
13%
Coronary Artery Disease
13%
Liver
13%
Colorectal Adenoma
13%
Randomized Trial
13%
Myocardial Infarction
13%
Inhaled Corticosteroids
12%
Metastatic Breast Cancer
12%
Lung Function
12%
Sleep Health
12%
Tumor Cells
12%
COVID-19
12%
Hispanic
11%
Lung Transplantation
11%
Cardiovascular Disease
11%
Human Prostate
11%
Early Breast Cancer
11%
Lung
11%
Sleep Disturbance
11%
Dietary Intervention
11%
Phase II Study
11%
Race-ethnicity
10%
Non-small Cell Lung Cancer (NSCLC)
10%
Overall Survival
10%
African American
10%
Weight Loss
10%
Tucson
10%
Doxorubicin
10%
Randomized Controlled Trial
10%
Breast Cancer Survivors
9%
Tumor Necrosis Factor-α
9%
Etoposide
9%
Gene Expression
9%
Childhood Asthma
9%
Cancer Patients
9%
Patients with Heart Failure
9%
Excessive Daytime Sleepiness
9%
Response Rate
9%
Lower Respiratory Tract Infection
9%
Older Adults
9%
Kidney
9%
High Risk
9%
Sleep Quality
9%
Immune Response
9%
Genome-wide Association Study
9%
Prostate Carcinoma
9%
Remission
8%
Non-Hispanic White
8%
Cancer Survivors
8%
Short Sleep Duration
8%
Prostate
8%
AIDS/HIV
8%
Community-based
8%
Allogeneic Bone Marrow Transplantation
8%
Forced Expiratory Volume in 1 Second (FEV1)
8%
Long Sleep
8%
Breast Cancer Risk
8%
Integrin
8%
Sleep Disorders
8%
Mortality Risk
8%
Colon Cancer
8%
Dietary Modification
8%
Protein Expression
8%
Prostate-specific Antigen
8%
Polymorphism
8%
Allergy
8%